Arun Kumar, Founder and Executive Chairperson of the Company, has served in various positions on the Board of Strides since its inception. His current appointment as Executive Director is expiring on ...

Strides Pharma Science is well on track to achieve the FY25 outlook of $275 million-$290 million, post-demerger.

Strides Pharma Science in its consolidated financial results for the quarter Q3FY25 ended December 31, 2024 reported revenues of Rs. 1,153.7 crore with a growth 14.6% YoY in Q3FY25. The PAT stood at ...

Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of ...

Revenue increased 15% YoY at ₹1,153.7 crore from ₹1,005.8 crore in Q3 FY24, marking a consistent business growth.

In an interview to CNBC-TV18, Arun Kumar, Executive VC and MD of Strides Shasun said the company may sell off its API unit after enhancing its value. The agreement was signed at the ASCI campus ...

Strides Pharma Science Ltd (BOM:532531) reports a robust quarter with 13.3% revenue growth and significant debt reduction, while navigating challenges in regulated markets.

He will succeed Arun Kumar, founder and the incumbent CEO and MD of the company, Strides Pharma Science said in a statement. "Arun will transition his active responsibilities at Strides by the ...

The promotor/promotors of Strides Pharma Science Ltd are Arun Kumar, Manjula Ramamurthy, Homi Rustam Khusrokhan, Badree Komandur, Kausalya Santhanam, Subir Chakraborty, Ameet Hariani, Aditya Kumar ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

With this achievement, Strides has secured a position in the ... the Company attained a commendable 87th percentile. Mr. Arun Kumar, Founder & Executive Chairperson, and Mr. Badree Komandur ...